RxDoctor Payments Data

Mariam Korah, MD

Radiation Oncology · Antioch, CANPI 1083891543

Payments from drug & device makers

$9,173in general payments, 2019–2025

Across 389 payments — averaging $23.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$1K
  • Merck$933
  • Takeda Pharmaceuticals U.S.A., Inc.$921
  • Novartis$616
  • Johnson & Johnson$430
  • Lilly USA, LLC$302
  • plus $5K from 54 others

What the payments were for

  • Food & beverage$9,173100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca(2 entities)47$1,176
Merck37$933
Takeda Pharmaceuticals U.S.A., Inc.66$921
Novartis23$616
Johnson & Johnson(2 entities)20$430
Lilly USA, LLC12$302
Seagen Inc.10$282
Amgen10$254
Puma Biotechnology, Inc.9$235
US Oncology Corporate, Inc.2$221
Regeneron Healthcare Solutions, Inc.7$199
Sobi, Inc7$186
Genentech USA, Inc.6$178
Eisai Inc.8$175
Daiichi Sankyo Inc.7$160
Incyte Corporation8$152
Progenics Pharmaceuticals, Inc.2$143
Taiho Oncology, Inc.6$136
Sanofi5$132
Pfizer5$129
Coherus Oncology, Inc.4$124
Bayer6$122
Bristol Myers Squibb5$120
Springworks Therapeutics, Inc.3$114
Boehringer Ingelheim5$113
Tersera Therapeutics LLC4$92
EMD Serono, Inc.5$88
Karyopharm Therapeutics Inc.3$88
Geron Corporation3$85
AbbVie3$81
GSK3$71
Pharmacyclics LLC, An Abbvie Company3$71
Beigene USA, Inc.3$69
Stemline Therapeutics Inc.2$60
Siemens Medical Solutions USA, Inc.1$56
AVEO Pharmaceuticals, Inc.2$54
Iovance Biotherapeutics, Inc.2$52
Kyowa Kirin, Inc.2$51
Agios Pharmaceuticals, Inc.2$47
Avanos Medical2$46
Clovis Oncology, Inc.2$45
Focal Therapeutics, Inc.2$44
E.r. Squibb & Sons, L.L.C.2$40
ADC Therapeutics America, Inc.2$38
Advanced Accelerator Applications2$33
Sumitomo Pharma America, Inc.1$31
Myovant Sciences Inc.1$29
Gilead1$29
Beone Medicines USA, Inc.1$29
Pharmacosmos Therapeutics Inc.1$26
Pharmaessentia USA Corporation1$25
Apellis Pharmaceuticals, Inc.1$24
Exelixis Inc.1$23
Sun Pharmaceutical Industries Inc.1$23
Intuitive Surgical1$23
Rigel Pharmaceuticals, Inc.2$22
Cardinal Health 414 LLC1$20
Deciphera Pharmaceuticals Inc.1$19
Organon1$19
Array Biopharma Inc1$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,173 in reported general payments places this provider in the 85th percentile of 627 radiation oncology providers in California.

See all radiation oncology providers in California

Medicare billing

Part B allowed, 2024
$998,508
Medicare patients
204
Services billed
3,178

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tamsulosin Hcl15$89

Paid to pharmacies, not to this prescriber.

Other radiation oncology in Antioch

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →